Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Urology|October 4, 2016
PTEN Loss in Gleason Score 3 + 4 = 7 Prostate Biopsies is Associated with Nonorgan Confined Disease at Radical ProstatectomyLiana B Guedes, Jeffrey J Tosoian, Jessica Hicks, et al.
The Journal of Molecular Diagnostics : JMD|December 5, 2021
Validation of Long Mononucleotide Repeat Markers for Detection of Microsatellite InstabilityJohn H Lin, Suping Chen, Aparna Pallavajjala, et al.
Prostate Cancer and Prostatic Diseases|January 6, 2018
p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancerBenjamin L Maughan, Liana B Guedes, Kenneth Boucher, et al.
The Journal of Molecular Diagnostics : JMD|June 1, 2021
Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate BiopsiesDaniela C Salles, Thiago Vidotto, Farzana A Faisal, et al.
The Journal of Urology|September 11, 2019
<i>PTEN</i> Loss with <i>ERG</i> Negative Status is Associated with Lethal Disease after Radical ProstatectomyNora M Haney, Farzana A Faisal, Jiayun Lu, et al.
Prostate Cancer and Prostatic Diseases|October 4, 2018
PTEN status assessment in the Johns Hopkins active surveillance cohortJeffrey J Tosoian, Liana B Guedes, Carlos L Morais, et al.
Oncotarget|February 11, 2017
Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriersTamara L Lotan, Alba Torres, Miao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2016
Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate CancerLiana B Guedes, Carlos L Morais, Fawaz Almutairi, et al.
Human Pathology|March 10, 2019
TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancerHarsimar B Kaur, Jiayun Lu, Liana B Guedes, et al.
Pageof 2